BioMedPartners

Quick Facts

AUM

$500M - $1B

AUM Category

$500M-$1B

Typical Ticket Size

$10M - $50M

Headquarters

Basel, Switzerland

Founded

2008

Team Size

50-100

About BioMedPartners

BioMedPartners is a prominent private equity firm specializing in investments within the life sciences and healthcare sectors. Established with a clear investment philosophy, the firm focuses on early to growth-stage companies that demonstrate innovative technologies and solutions aimed at improving patient outcomes. Their typical deal thesis revolves around identifying companies with strong intellectual property, sustainable business models, and significant market potential. BioMedPartners seeks to partner with management teams that are committed to advancing their businesses, providing both capital and strategic support to drive growth and operational improvements. The firm has a well-defined sector expertise, particularly in biopharmaceuticals, medical devices, diagnostics, and digital health. BioMedPartners targets portfolio companies that are positioned to address unmet medical needs or enhance existing healthcare delivery systems. By concentrating on these sectors, the firm leverages its deep industry knowledge and extensive networks to identify promising investment opportunities. This focus not only allows BioMedPartners to conduct thorough due diligence but also equips them to add value post-investment through strategic guidance and operational enhancements. What sets BioMedPartners apart in the private equity landscape is their commitment to fostering innovation and their robust understanding of the regulatory and reimbursement landscapes that govern the healthcare industry. The firm’s team comprises professionals with extensive backgrounds in both investment and operational roles within the life sciences sector, enabling them to offer targeted support to their portfolio companies. Their collaborative approach emphasizes building long-term relationships with entrepreneurs and management teams, which is critical for navigating the complexities associated with bringing new therapies and technologies to market. For interim executives considering a partnership with BioMedPartners, it is essential to recognize the firm’s focus on transformational growth and innovation within the healthcare space. Executives should be prepared to engage in a dynamic environment where agility and strategic foresight are paramount. Understanding the specific challenges and opportunities within the life sciences sector will be crucial for aligning with BioMedPartners’ goals and effectively contributing to the success of their portfolio companies. Overall, the firm’s emphasis on partnership and operational excellence can provide a fertile ground for interim executives to leverage their expertise in driving impactful change.

Investment Focus

Sectors: Healthcare

Investment Stages: Venture, Growth

Portfolio Focus: HealthTech

Regional Offices

• Zurich

Connect with BioMedPartners

• Website

Frequently Asked Questions

Is BioMedPartners a private equity firm?

Yes, BioMedPartners is a private equity firm headquartered in Basel, Switzerland, founded in 2008.

What is BioMedPartners's AUM (assets under management)?

BioMedPartners manages approximately $500M - $1B in assets under management.

What is BioMedPartners's typical ticket size?

BioMedPartners typically invests $10M - $50M per deal.

Where is BioMedPartners headquartered?

BioMedPartners is headquartered in Basel, Switzerland. Regional offices include Zurich.

What sectors does BioMedPartners invest in?

BioMedPartners invests across Healthcare.

What investment stages does BioMedPartners focus on?

BioMedPartners focuses on Venture, Growth investments.

When was BioMedPartners founded?

BioMedPartners was founded in 2008.